Related Experiment Video
Updated: Apr 21, 2026

07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
3.3K
Extracting Relevant Information from FDA Drug Files to Create a Structurally Diverse Drug Database Using KnowItAll®
Malcolm J D'Souza1, Fumie Koyoshi1
1Department of Chemistry, Wesley College, 120 N. State Street, Dover, Delaware 19901-3875, USA.
Summary
This project extracts valuable drug data from FDA files for educational use. Undergraduates gain practical skills in computational chemistry and pharmacology by analyzing drug properties and reactions.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Food and Drug Administration (FDA) drug files contain extensive chemical, pharmaceutical, and pharmacological data.
- Utilizing this data in educational settings offers a novel method to bridge theoretical knowledge with practical application.
- Existing informatics systems can integrate and analyze this complex drug information.
Purpose of the Study:
- To extract essential data for 75 orally administered drugs from FDA files.
- To develop a searchable database of this extracted drug information.
- To enhance undergraduate education in organic chemistry, molecular biology, and physiology through hands-on data analysis.
Main Methods:
- Information extraction from FDA consumer drug information files for 75 selected drugs.
- Development of an indexed database for efficient search and analysis of drug properties.
- Utilizing the KnowItAll Informatics System for data management and computational analysis.
Main Results:
- Successfully extracted and organized data on chemical structure, ADME/Tox, and adverse reactions for 75 drugs.
- Created a functional database enabling indexed search and analysis of pharmaceutical information.
- Undergraduates demonstrated improved skills in data harvesting, computational chemistry, and scientific vocabulary.
Conclusions:
- The project successfully demonstrated the value of FDA drug files as an educational resource.
- Integration of real-world drug data enhances student understanding of theoretical concepts.
- This approach equips students with practical computational chemistry skills and a deeper understanding of drug action.
Related Concept Videos
Drug Discovery: Overview
10.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Drug Nomenclature
3.3K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.3K
Drug Biotransformation: Overview
3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Drug Biotransformation: Overview
6.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
6.4K
Drug Distribution: Tissue Binding
3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.7K

